MicroRNA-34a Mediates the Autocrine Signaling of PAR2-Activating Proteinase and Its Role in Colonic Cancer Cell Proliferation

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Ma, Yiming ^a   Bao Han, Wuyun ^a   Lv, Xue ^a   Su, Yuntao ^b   Zhao, Xinhua ^a   Yin, Yongmei ^b   Zhang, Xingmao ^a   Zhou, Zhixiang ^a   MacNaughton, Wallace K ^c   Wang, Hongying ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DNA; MICRORNA 34A; PROTEINASE ACTIVATED RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENICITY; CELL PROLIFERATION; CELL STRAIN HT29; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN DEFICIENCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING;

BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN D1; DNA PRIMERS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICRORNAS; POLYMERASE CHAIN REACTION; RECEPTOR, PAR-2; RNA PROCESSING, POST-TRANSCRIPTIONAL; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84883056969     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072383     Document Type: Article

References (40)

1. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C, (2003) Human and mouse proteases: a comparative genomic approach. Nat Rev Genet 4: 544-558.
2. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R, (2001) Proteinase-activated receptors. Pharmacol Rev 53: 245-282.
3. Versteeg HH, Schaffner F, Kerver M, Ellies LG, Andrade-Gordon P, et al. (2008) Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res 68: 7219-7227.
4. Ramachandran R, Noorbakhsh F, DeFea K, Hollenberg MD, (2012) Targeting proteinase-activated receptors: therapeutic potential and challenges. Nat Rev Drug Discov 11: 69-86.
5. Elste AP, Petersen I, (2010) Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer. J Mol Histol 41: 89-99.
6. Ohta T, Shimizu K, Yi S, Takamura H, Amaya K, et al. (2003) Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers. Int J Oncol 23: 61-66.
7. Darmoul D, Gratio V, Devaud H, Laburthe M, (2004) Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. J Biol Chem 279: 20927-20934.
8. Darmoul D, Marie JC, Devaud H, Gratio V, Laburthe M, (2001) Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer 85: 772-779.
9. Jikuhara A, Yoshii M, Iwagaki H, Mori S, Nishibori M, et al. (2003) MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2. Life Sci 73: 2817-2829.
10. Miyata S, Koshikawa N, Yasumitsu H, Miyazaki K, (2000) Trypsin stimulates integrin alpha(5)beta(1)-dependent adhesion to fibronectin and proliferation of human gastric carcinoma cells through activation of proteinase-activated receptor-2. J Biol Chem 275: 4592-4598.
11. McKerrow JH, Bhargava V, Hansell E, Huling S, Kuwahara T, et al. (2000) A functional proteomics screen of proteases in colorectal carcinoma. Mol Med 6: 450-460.
12. Yamamoto H, Iku S, Adachi Y, Imsumran A, Taniguchi H, et al. (2003) Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol 199: 176-184.
13. Miyata S, Miyagi Y, Koshikawa N, Nagashima Y, Kato Y, et al. (1998) Stimulation of cellular growth and adhesion to fibronectin and vitronectin in culture and tumorigenicity in nude mice by overexpression of trypsinogen in human gastric cancer cells. Clin Exp Metastasis 16: 613-622.
14. Ikeda O, Egami H, Ishiko T, Ishikawa S, Kamohara H, et al. (2003) Expression of proteinase-activated receptor-2 in human pancreatic cancer: a possible relation to cancer invasion and induction of fibrosis. Int J Oncol 22: 295-300.
15. Bohm SK, Kong W, Bromme D, Smeekens SP, Anderson DC, et al. (1996) Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J 314 (Pt 3): 1009-1016.
16. Ribeiro FS, Simao TA, Amoedo ND, Andreollo NA, Lopes LR, et al. (2009) Evidence for increased expression of tissue factor and protease-activated receptor-1 in human esophageal cancer. Oncol Rep 21: 1599-1604.
17. Jin X, Hirosaki T, Lin CY, Dickson RB, Higashi S, et al. (2005) Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin. J Cell Biochem 95: 632-647.
18. Ducroc R, Bontemps C, Marazova K, Devaud H, Darmoul D, et al. (2002) Trypsin is produced by and activates protease-activated receptor-2 in human cancer colon cells: evidence for new autocrine loop. Life Sci 70: 1359-1367.
19. Gratio V, Loriot C, Virca GD, Oikonomopoulou K, Walker F, et al. (2011) Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells. Am J Pathol 179: 2625-2636.
20. Wang H, Wen S, Bunnett NW, Leduc R, Hollenberg MD, et al. (2008) Proteinase-activated Receptor-2 Induces Cyclooxygenase-2 Expression through-Catenin and Cyclic AMP-response Element-binding Protein. J Biol Chem 283: 809-815.
21. Jiang Q, Feng MG, Mo YY, (2009) Systematic validation of predicted microRNAs for cyclin D1. BMC Cancer 9: 194.
22. Lee RC, Feinbaum RL, Ambros V, (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
23. Wightman B, Ha I, Ruvkun G, (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855-862.
24. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, et al. (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766-770.
25. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
26. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
27. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
28. Lee YS, Dutta A, (2009) MicroRNAs in cancer. Annu Rev Pathol 4: 199-227.
29. Ma Y, Li W, Wang H (2012) Roles of miRNA in the initiation and development of colorectal carcinoma. Curr Pharm Des.
30. Lee YS, Kim HK, Chung S, Kim KS, Dutta A, (2005) Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J Biol Chem 280: 16635-16641.
31. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756.
32. Akao Y, Nakagawa Y, Naoe T, (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29: 903-906.
33. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, et al. (2004) MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 279: 52361-52365.
34. Green D, Karpatkin S, (2010) Role of thrombin as a tumor growth factor. Cell Cycle 9: 656-661.
35. Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, et al. (2009) miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 69: 5553-5559.
36. Xia W, Li J, Chen L, Huang B, Li S, et al. (2010) MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells. Mol Cell Biochem 344: 261-266.
37. Zhao C, Sun G, Li S, Lang MF, Yang S, et al. (2010) MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling. Proc Natl Acad Sci U S A 107: 1876-1881.
38. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H, (2007) Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A 104: 15472-15477.
39. Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, et al. (2012) TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 22: 291-303.
40. Knight V, Tchongue J, Lourensz D, Tipping P, Sievert W, (2012) Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells. Hepatology 55: 879-887.